Do Younger Patients Undergoing Transfibular Total Ankle Arthroplasty Achieve Outcomes Comparable with Those of Older Patients? Interpreting Nonsignificant Differences in Clinical Research

Total ankle arthroplasty (TAA) has traditionally been reserved for older, lower-demand patients because of concerns regarding implant longevity and functional demands in younger individuals. With advances in implant design and surgical technique, however, its indications have continued to expand, leading to increased interest in the outcomes of this procedure in younger patients. In this context, the study by Schafer et al. provides timely and clinically relevant midterm data on primary transfibular TAA outcomes at a mean follow-up of approximately 7 years. The authors report high implant survivorship and favorable clinical and radiographic outcomes in both younger and older cohorts. After multivariable adjustment, no significant associations were detected between the age group and patient-reported outcomes, alignment, or range of motion. These findings are of clinical interest, particularly given the proposed advantages of the transfibular approach, including limited bone resection and implantation in relatively denser bone, which may have implications for durability in younger patients. Importantly, the authors explicitly acknowledge a key interpretive consideration: the absence of significant associations should not be interpreted as confirmation that age-related differences do not exist. This distinction is fundamental in clinical research. Within the framework of null-hypothesis significance testing, failure to detect a significant difference does not establish that groups are comparable; rather, it indicates that the available data do not provide sufficient evidence to reject the null hypothesis. As has been widely emphasized, “absence of evidence is not evidence of absence.”1 Demonstrating that outcomes are comparable requires a distinct analytical framework, typically involving prespecified equivalence or noninferiority margins and sufficient statistical power to exclude clinically meaningful differences2. Without such a framework, nonsignificant results should be interpreted cautiously and primarily as descriptive. This issue is particularly relevant in the evaluation of TAA in younger patients. Several prior studies have reported less favorable outcomes in younger cohorts, including higher complication rates, increased revision risk, or inferior functional outcomes compared with older patients. Notably, Anastasio et al. demonstrated higher complication rates and worse functional outcomes in younger individuals undergoinganterior-approach TAA. Similar concerns have been raised in earlier investigations, which reported higher revision rates or less favorable survivorship in patients younger than 55 years, as well as age-related differences in clinical outcomes3–5. Collectively, these studies suggest that younger age may be associated with less favorable outcomes following TAA, underscoring the importance of cautious interpretation when expanding indications to this population. Importantly, the present study contributes meaningful evidence despite these considerations. The observation that favorable midterm outcomes were achieved in both younger and older patients supports the possibility that transfibular TAA may be considered across a broader age spectrum than traditionally recommended. At the same time, as the authors appropriately note, the current data do not establish equivalence between the age groups. Future research should aim to address this question more directly. Studies specifically designed to evaluate equivalence or noninferiority, with clearly defined clinical margins and adequate statistical power, will be essential to determine whether outcomes in younger patients are truly comparable with those in older populations. In addition, longer-term follow-up remains critical, particularly given concerns regarding implant durability in more active individuals. In summary, this study provides valuable midterm evidence supporting the use of transfibular TAA in both younger and older patients. As emphasized by the study authors, careful interpretation of nonsignificant findings is essential. Recognizing the distinction between absence of significance and evidence of comparability will be key to ensuring that clinical conclusions remain aligned with the strength of the available evidence.